Guillain-Barre Syndrome Epidemiology Forecast to 2030

April 16 18:50 2020
Guillain-Barre Syndrome Epidemiology Forecast to 2030

Delveinsight Business Research
DelveInsight’s ‘Guillain-Barré Syndrome Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Guillain-Barré Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Guillain–Barré Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks part of its peripheral nervous system—the network of nerves located outside of the brain and spinal cord. GBS can range from a very mild case with a brief weakness to nearly devastating paralysis, leaving the person unable to breathe independently. Most people eventually recover from even the most severe cases of GBS. After recovery, some people will continue to have some degree of weakness.

There are several types of Guillain–Barré syndrome, classified by the part of the peripheral nerve involved in the condition. The most common type of Guillain–Barré syndrome are:

  • Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP)

  • Miller Fisher syndrome

  • Acute Motor Axonal Neuropathy (AMAN) and Acute Motor‐sensory Axonal Neuropathy (AMSAN)

The DelveInsight Guillain-Barré Syndrome epidemiology report gives a thorough understanding of the Guillain-Barré Syndrome by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. 

It also provides treatment algorithms and treatment guidelines for Guillain-Barré Syndrome in the US, Europe, and Japan. The report covers the detailed information of the Guillain-Barré Syndrome epidemiology scenario in seven major countries (US, EU5, and Japan).

 

Key Highlights Of The Report

As per the “National Institute of Health,” the Incidence of Guillain–Barré Syndrome is estimated to be 6–40 cases per 1 million people.

As per the “National Institute of Health”, AMAN and AMSAN together account for 30–50 % of cases in Asian countries and Latin America but only 3–5 % of cases in North America and Europe.

Another study titled “Incidence of Guillain–Barré Syndrome in Germany “, by Lehmann et al. (2008), the estimated incidence rates of GBS in Germany between 2003 and 2005 ranged from 1.6 to 1.89 per 100,000, with a mean incidence rate of 1.75 per 100,000.

As per the “World Health Organization,” Guillain–Barré Syndrome is more common in males.

 Guillain-Barré Syndrome Epidemiology

Request for Sample Pages: 

https://www.delveinsight.com/sample-request/guillain-barre-syndrome-gbs-epidemiology-forecast

 

Guillain-Barré Syndrome Epidemiology

Delveinsight’s Guillain-Barré Syndrome epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. 

The Guillain-Barré Syndrome epidemiology data are studied through all possible divisions to give a better understanding of the Disease scenario in 7MM. 

The Guillain-Barré Syndrome epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. 

It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

 

Scope of the Report

  • The report provides insight into the historical and forecasted patient pool of Guillain-Barré Syndrome in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

  • The report assesses the disease risk and burden and highlights the unmet needs of Guillain-Barré Syndrome.

  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.

  • The Guillain-Barré Syndrome report provides a detailed overview explaining Guillain-Barré Syndrome causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns.

  • The Guillain-Barré Syndrome Epidemiology Report and Model provide an overview of the risk factors and global trends of Guillain-Barré Syndrome in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan).

  • The report provides the segmentation of the Guillain-Barré Syndrome epidemiology. 

 

Key Questions Covered In The Guillain-Barré Syndrome Report Include:

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Guillain-Barré Syndrome?

  • What are the key findings pertaining to the Guillain-Barré Syndrome epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?

  • What would be the total number of patients of Guillain-Barré Syndrome across the 7MM during the forecast period (2017-2030)?

  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?

  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?

  • What is the disease risk, burden and unmet needs of the Guillain-Barré Syndrome?

  • What are the currently available treatments of Guillain-Barré Syndrome?

 

Key Benefit of Guillain-Barré Syndrome Epidemiology Report 

  • The Guillain-Barré Syndrome Epidemiology report will allow the user to –

  • Develop business strategies by understanding the trends shaping and driving the global Guillain-Barré Syndrome market

  • Quantify patient populations in the global Guillain-Barré Syndrome market to improve product design, pricing, and launch plans

  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Guillain-Barré Syndrome therapeutics in each of the markets covered

  • Understand the magnitude of Guillain-Barré Syndrome population by its epidemiology

  • The Guillain-Barré Syndrome Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

Table of Contents

  1. Key Insights 

  2. Executive Summary of Guillain-Barré Syndrome

  3. Guillain-Barré Syndrome Disease Background and Overview

  • Guillain-Barré Syndrome Sign and Symptoms

  • Guillain-Barré Syndrome Pathophysiology

  • Guillain-Barré Syndrome Risk Factors

  • Guillain-Barré Syndrome Diagnosis

  1. Guillain-Barré Syndrome Patient Journey

  2. Guillain-Barré Syndrome Epidemiology and Patient Population

  3. Guillain-Barré Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

  4. KOL Views on Guillain-Barré Syndrome 

  5. Guillain-Barré Syndrome Unmet Needs

  6. Appendix

  7. DelveInsight Capabilities

  8. Disclaimer

*The table of contents is not exhaustive; will be provided in the final report

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Guillain-Barre Syndrome (GBS) Market Insight, Epidemiology and Market Forecast 2030
DelveInsight’ s Guillain-Barre Syndrome (GBS) Market Insights, Epidemiology and Market Forecast 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

 

Guillain-Barre Syndrome Pipeline Insights, 2020

Guillain-Barre Syndrome Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Guillain-Barre Syndrome market.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/